Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.

A new slow-release implant has shown unprecedented success in wiping out bladder cancer in more than 80 percent of patients, ...

Doctors at KIMS Hospital in Kurnool successfully performed complex surgery on a woman suffering from complications after a hysterectomy.

Learn essential post-surgery insights for prostate cancer patients to ensure a smooth recovery and return to daily life.

A local surgeon Dr Augustine Melly successfully performed the first holmium laser lithotripsy for bladder stones in the ...

POSTOPERATIVE urinary retention is a common and costly complication following minimally invasive inguinal hernia repair (MIS-IHR). Rates of postoperative urinary ...

The standing ovation for Keytruda and Padcev in metastatic bladder cancer at the 2023 European Society for Medical Oncology (ESMO) Congress still echoes, and, now, the pair from Merck & Co., Pfizer ...

Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, reducing disease progression or death risk by 60%. The EV-303/KEYNOTE-905 trial ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) reduced the ...